Literature DB >> 26800663

[Translational research in pediatric rheumatology. Current research approaches to the innate immune system].

K Lippitz1, J Waldkirch1, C Kessel1, G Varga1, D Foell2.   

Abstract

Translational research aims at closely linking basic research and clinical observations so that important mechanistic insights identified in one field should trigger progress in the other. Particularly in the field of pediatric rheumatology this approach has significantly improved the understanding and therapy of several diseases in recent years. One focus of our research in this respect is on the structure, release mechanisms and function of damage associated molecular patterns (DAMP), particularly S100 proteins. Due to their huge potential as inflammation biomarkers for more specific diagnostics these proteins are of particular clinical interest. Overactivated cells of the innate immune system play a crucial role in the development of rheumatic diseases. Innate mechanisms, such as the generation of neutrophil extracellular traps (NETosis) were linked to the pathogenesis of inflammatory diseases, such as systemic lupus erythematosus and rheumatoid arthritis. Furthermore, it became increasingly more evident that various excessive sterile inflammatory mechanisms and reactions significantly contribute to an activation of adaptive immune responses and thus to the development of autoimmunity. Studying such potentially DAMP-dependent pathways at the interface between innate and adaptive immunity can provide a better understanding of autoinflammatory conditions in pediatric rheumatology and to identify novel targets for optimization of therapy.

Entities:  

Keywords:  Autoinflammation; Damage associated molecular pattern; Neutrophil extracellular traps; Rheumatoid arthritis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 26800663     DOI: 10.1007/s00393-015-0040-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  61 in total

1.  The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.

Authors:  Dirk Holzinger; Michael Frosch; Astrid Kastrup; Femke H M Prince; Marieke H Otten; Lisette W A Van Suijlekom-Smit; Rebecca ten Cate; Esther P A H Hoppenreijs; Sandra Hansmann; Halima Moncrieffe; Simona Ursu; Lucy R Wedderburn; Johannes Roth; Dirk Foell; Helmut Wittkowski
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

2.  S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity.

Authors:  Zheng Yang; Wei Xing Yan; Hong Cai; Nicodemus Tedla; Chris Armishaw; Nick Di Girolamo; Hong Wei Wang; Taline Hampartzoumian; Jodie L Simpson; Peter G Gibson; John Hunt; Prue Hart; J Margaret Hughes; Michael A Perry; Paul F Alewood; Carolyn L Geczy
Journal:  J Allergy Clin Immunol       Date:  2006-10-06       Impact factor: 10.793

3.  Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products.

Authors:  J Li; A M Schmidt
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

Review 4.  From bench to bedside and back again: translational research in autoinflammation.

Authors:  Dirk Holzinger; Christoph Kessel; Alessia Omenetti; Marco Gattorno
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

5.  MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.

Authors:  Helmut Wittkowski; Jasmin B Kuemmerle-Deschner; Judith Austermann; Dirk Holzinger; Raphaela Goldbach-Mansky; Katharina Gramlich; Peter Lohse; Thomas Jung; Johannes Roth; Susanne M Benseler; Dirk Foell
Journal:  Ann Rheum Dis       Date:  2011-09-08       Impact factor: 19.103

6.  S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14.

Authors:  T Vogl; C Pröpper; M Hartmann; A Strey; K Strupat; C van den Bos; C Sorg; J Roth
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

7.  Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue.

Authors:  M Gattorno; L Chicha; A Gregorio; F Ferlito; F Rossi; D Jarrossay; A Lanzavecchia; A Martini; M G Manz
Journal:  Rheumatology (Oxford)       Date:  2006-11-03       Impact factor: 7.580

8.  Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture.

Authors:  Jesse Goyette; Wei Xing Yan; Eric Yamen; Yuen Ming Chung; Su Yin Lim; Kenneth Hsu; Farid Rahimi; Nick Di Girolamo; Changjie Song; Wendy Jessup; Maaike Kockx; Yuri V Bobryshev; S Ben Freedman; Carolyn L Geczy
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

9.  Novel cell death program leads to neutrophil extracellular traps.

Authors:  Tobias A Fuchs; Ulrike Abed; Christian Goosmann; Robert Hurwitz; Ilka Schulze; Volker Wahn; Yvette Weinrauch; Volker Brinkmann; Arturo Zychlinsky
Journal:  J Cell Biol       Date:  2007-01-08       Impact factor: 10.539

10.  Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function.

Authors:  Olga V Moroz; Will Burkitt; Helmut Wittkowski; Wei He; Anatoli Ianoul; Vera Novitskaya; Jingjing Xie; Oxana Polyakova; Igor K Lednev; Alexander Shekhtman; Peter J Derrick; Per Bjoerk; Dirk Foell; Igor B Bronstein
Journal:  BMC Biochem       Date:  2009-04-23       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.